 | • レポートコード：QYR2104Z3528 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、大うつ病性障害（MDD）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗うつ薬、SSRI、SNRI、ベンゾジアゼピン、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・大うつ病性障害（MDD）の市場動向 ・企業の競争状況、市場シェア ・大うつ病性障害（MDD）の種類別市場規模（抗うつ薬、SSRI、SNRI、ベンゾジアゼピン、その他） ・大うつ病性障害（MDD）の用途別市場規模（病院、クリニック、その他） ・大うつ病性障害（MDD）の北米市場規模2016-2027（アメリカ、カナダ） ・大うつ病性障害（MDD）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・大うつ病性障害（MDD）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・大うつ病性障害（MDD）の中南米市場規模2016-2027（メキシコ、ブラジル） ・大うつ病性障害（MDD）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、GlaxoSmithKline、Merck、AstraZeneca、Eli Lily、Johnson & Johnson、Forest Laboratories、Sanofi-Aventis、H. Lundbeck、Bristol-Myers Squibb） ・結論 |
Major Depressive Disorder (MDD) is a common mental illness characterized by persistent low mood that interferes with the person’s ability to eat, work, sleep and other activities. MDD is also referred to as clinical depression or recurrent depression. The common symptoms of this mental disorder are insomnia, loss of interest, recurrent thoughts of death, feelings of worthlessness and reduced ability to think. The rising prevalence of major depression has led to a sharp increase in the patient volume suffering from depression. Currently, many treatments and therapies are available for major depression but the market still holds a large scope of growth opportunities with high unmet needs of the market.
The rising geriatric population prone to depression and surging prevalence of anxiety disorders, including phobias and generalized anxiety disorder, are further contributing toward the growing demand for antidepressants to treat mental illnesses over the forecast period. Moreover, the introduction of technologically advanced therapies, such as medical implants used for brain stimulation and virtual reality exposure therapies using smartphone-based applications, furnish patients with innovative treatment alternatives.
Market Analysis and Insights: Global Major Depressive Disorder (MDD) Market
The global Major Depressive Disorder (MDD) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Major Depressive Disorder (MDD) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Major Depressive Disorder (MDD) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Major Depressive Disorder (MDD) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Major Depressive Disorder (MDD) market.
Global Major Depressive Disorder (MDD) Scope and Market Size
Major Depressive Disorder (MDD) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Major Depressive Disorder (MDD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antidepressant Drugs
SSRIs
SNRIs
Benzodiazepines
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
GlaxoSmithKline
Merck
AstraZeneca
Eli Lily
Johnson & Johnson
Forest Laboratories
Sanofi-Aventis
H. Lundbeck
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Major Depressive Disorder (MDD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antidepressant Drugs
1.2.3 SSRIs
1.2.4 SNRIs
1.2.5 Benzodiazepines
1.2.6 Others
1.3 Market by Application
1.3.1 Global Major Depressive Disorder (MDD) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Major Depressive Disorder (MDD) Market Perspective (2016-2027)
2.2 Major Depressive Disorder (MDD) Growth Trends by Regions
2.2.1 Major Depressive Disorder (MDD) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Major Depressive Disorder (MDD) Historic Market Share by Regions (2016-2021)
2.2.3 Major Depressive Disorder (MDD) Forecasted Market Size by Regions (2022-2027)
2.3 Major Depressive Disorder (MDD) Industry Dynamic
2.3.1 Major Depressive Disorder (MDD) Market Trends
2.3.2 Major Depressive Disorder (MDD) Market Drivers
2.3.3 Major Depressive Disorder (MDD) Market Challenges
2.3.4 Major Depressive Disorder (MDD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Major Depressive Disorder (MDD) Players by Revenue
3.1.1 Global Top Major Depressive Disorder (MDD) Players by Revenue (2016-2021)
3.1.2 Global Major Depressive Disorder (MDD) Revenue Market Share by Players (2016-2021)
3.2 Global Major Depressive Disorder (MDD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Major Depressive Disorder (MDD) Revenue
3.4 Global Major Depressive Disorder (MDD) Market Concentration Ratio
3.4.1 Global Major Depressive Disorder (MDD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Major Depressive Disorder (MDD) Revenue in 2020
3.5 Major Depressive Disorder (MDD) Key Players Head office and Area Served
3.6 Key Players Major Depressive Disorder (MDD) Product Solution and Service
3.7 Date of Enter into Major Depressive Disorder (MDD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Major Depressive Disorder (MDD) Breakdown Data by Type
4.1 Global Major Depressive Disorder (MDD) Historic Market Size by Type (2016-2021)
4.2 Global Major Depressive Disorder (MDD) Forecasted Market Size by Type (2022-2027)
5 Major Depressive Disorder (MDD) Breakdown Data by Application
5.1 Global Major Depressive Disorder (MDD) Historic Market Size by Application (2016-2021)
5.2 Global Major Depressive Disorder (MDD) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Major Depressive Disorder (MDD) Market Size (2016-2027)
6.2 North America Major Depressive Disorder (MDD) Market Size by Type
6.2.1 North America Major Depressive Disorder (MDD) Market Size by Type (2016-2021)
6.2.2 North America Major Depressive Disorder (MDD) Market Size by Type (2022-2027)
6.2.3 North America Major Depressive Disorder (MDD) Market Size by Type (2016-2027)
6.3 North America Major Depressive Disorder (MDD) Market Size by Application
6.3.1 North America Major Depressive Disorder (MDD) Market Size by Application (2016-2021)
6.3.2 North America Major Depressive Disorder (MDD) Market Size by Application (2022-2027)
6.3.3 North America Major Depressive Disorder (MDD) Market Size by Application (2016-2027)
6.4 North America Major Depressive Disorder (MDD) Market Size by Country
6.4.1 North America Major Depressive Disorder (MDD) Market Size by Country (2016-2021)
6.4.2 North America Major Depressive Disorder (MDD) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Major Depressive Disorder (MDD) Market Size (2016-2027)
7.2 Europe Major Depressive Disorder (MDD) Market Size by Type
7.2.1 Europe Major Depressive Disorder (MDD) Market Size by Type (2016-2021)
7.2.2 Europe Major Depressive Disorder (MDD) Market Size by Type (2022-2027)
7.2.3 Europe Major Depressive Disorder (MDD) Market Size by Type (2016-2027)
7.3 Europe Major Depressive Disorder (MDD) Market Size by Application
7.3.1 Europe Major Depressive Disorder (MDD) Market Size by Application (2016-2021)
7.3.2 Europe Major Depressive Disorder (MDD) Market Size by Application (2022-2027)
7.3.3 Europe Major Depressive Disorder (MDD) Market Size by Application (2016-2027)
7.4 Europe Major Depressive Disorder (MDD) Market Size by Country
7.4.1 Europe Major Depressive Disorder (MDD) Market Size by Country (2016-2021)
7.4.2 Europe Major Depressive Disorder (MDD) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Major Depressive Disorder (MDD) Market Size (2016-2027)
8.2 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Type
8.2.1 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Type (2016-2027)
8.3 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Application
8.3.1 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Application (2016-2027)
8.4 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region
8.4.1 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Major Depressive Disorder (MDD) Market Size (2016-2027)
9.2 Latin America Major Depressive Disorder (MDD) Market Size by Type
9.2.1 Latin America Major Depressive Disorder (MDD) Market Size by Type (2016-2021)
9.2.2 Latin America Major Depressive Disorder (MDD) Market Size by Type (2022-2027)
9.2.3 Latin America Major Depressive Disorder (MDD) Market Size by Type (2016-2027)
9.3 Latin America Major Depressive Disorder (MDD) Market Size by Application
9.3.1 Latin America Major Depressive Disorder (MDD) Market Size by Application (2016-2021)
9.3.2 Latin America Major Depressive Disorder (MDD) Market Size by Application (2022-2027)
9.3.3 Latin America Major Depressive Disorder (MDD) Market Size by Application (2016-2027)
9.4 Latin America Major Depressive Disorder (MDD) Market Size by Country
9.4.1 Latin America Major Depressive Disorder (MDD) Market Size by Country (2016-2021)
9.4.2 Latin America Major Depressive Disorder (MDD) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Major Depressive Disorder (MDD) Market Size (2016-2027)
10.2 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Type
10.2.1 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Type (2016-2027)
10.3 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Application
10.3.1 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Application (2016-2027)
10.4 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country
10.4.1 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Major Depressive Disorder (MDD) Introduction
11.1.4 Pfizer Revenue in Major Depressive Disorder (MDD) Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Major Depressive Disorder (MDD) Introduction
11.2.4 GlaxoSmithKline Revenue in Major Depressive Disorder (MDD) Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Major Depressive Disorder (MDD) Introduction
11.3.4 Merck Revenue in Major Depressive Disorder (MDD) Business (2016-2021)
11.3.5 Merck Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Major Depressive Disorder (MDD) Introduction
11.4.4 AstraZeneca Revenue in Major Depressive Disorder (MDD) Business (2016-2021)
11.4.5 AstraZeneca Recent Development
11.5 Eli Lily
11.5.1 Eli Lily Company Details
11.5.2 Eli Lily Business Overview
11.5.3 Eli Lily Major Depressive Disorder (MDD) Introduction
11.5.4 Eli Lily Revenue in Major Depressive Disorder (MDD) Business (2016-2021)
11.5.5 Eli Lily Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Major Depressive Disorder (MDD) Introduction
11.6.4 Johnson & Johnson Revenue in Major Depressive Disorder (MDD) Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Forest Laboratories
11.7.1 Forest Laboratories Company Details
11.7.2 Forest Laboratories Business Overview
11.7.3 Forest Laboratories Major Depressive Disorder (MDD) Introduction
11.7.4 Forest Laboratories Revenue in Major Depressive Disorder (MDD) Business (2016-2021)
11.7.5 Forest Laboratories Recent Development
11.8 Sanofi-Aventis
11.8.1 Sanofi-Aventis Company Details
11.8.2 Sanofi-Aventis Business Overview
11.8.3 Sanofi-Aventis Major Depressive Disorder (MDD) Introduction
11.8.4 Sanofi-Aventis Revenue in Major Depressive Disorder (MDD) Business (2016-2021)
11.8.5 Sanofi-Aventis Recent Development
11.9 H. Lundbeck
11.9.1 H. Lundbeck Company Details
11.9.2 H. Lundbeck Business Overview
11.9.3 H. Lundbeck Major Depressive Disorder (MDD) Introduction
11.9.4 H. Lundbeck Revenue in Major Depressive Disorder (MDD) Business (2016-2021)
11.9.5 H. Lundbeck Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Details
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Major Depressive Disorder (MDD) Introduction
11.10.4 Bristol-Myers Squibb Revenue in Major Depressive Disorder (MDD) Business (2016-2021)
11.10.5 Bristol-Myers Squibb Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Major Depressive Disorder (MDD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antidepressant Drugs
Table 3. Key Players of SSRIs
Table 4. Key Players of SNRIs
Table 5. Key Players of Benzodiazepines
Table 6. Key Players of Others
Table 7. Global Major Depressive Disorder (MDD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Major Depressive Disorder (MDD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Major Depressive Disorder (MDD) Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Major Depressive Disorder (MDD) Market Share by Regions (2016-2021)
Table 11. Global Major Depressive Disorder (MDD) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Major Depressive Disorder (MDD) Market Share by Regions (2022-2027)
Table 13. Major Depressive Disorder (MDD) Market Trends
Table 14. Major Depressive Disorder (MDD) Market Drivers
Table 15. Major Depressive Disorder (MDD) Market Challenges
Table 16. Major Depressive Disorder (MDD) Market Restraints
Table 17. Global Major Depressive Disorder (MDD) Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Major Depressive Disorder (MDD) Market Share by Players (2016-2021)
Table 19. Global Top Major Depressive Disorder (MDD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Major Depressive Disorder (MDD) as of 2020)
Table 20. Ranking of Global Top Major Depressive Disorder (MDD) Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Major Depressive Disorder (MDD) Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Major Depressive Disorder (MDD) Product Solution and Service
Table 24. Date of Enter into Major Depressive Disorder (MDD) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Major Depressive Disorder (MDD) Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Major Depressive Disorder (MDD) Revenue Market Share by Type (2016-2021)
Table 28. Global Major Depressive Disorder (MDD) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Major Depressive Disorder (MDD) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Major Depressive Disorder (MDD) Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Major Depressive Disorder (MDD) Revenue Market Share by Application (2016-2021)
Table 32. Global Major Depressive Disorder (MDD) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Major Depressive Disorder (MDD) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Major Depressive Disorder (MDD) Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Major Depressive Disorder (MDD) Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Major Depressive Disorder (MDD) Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Major Depressive Disorder (MDD) Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Major Depressive Disorder (MDD) Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Major Depressive Disorder (MDD) Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Major Depressive Disorder (MDD) Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Major Depressive Disorder (MDD) Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Major Depressive Disorder (MDD) Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Major Depressive Disorder (MDD) Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Major Depressive Disorder (MDD) Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Major Depressive Disorder (MDD) Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Major Depressive Disorder (MDD) Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Major Depressive Disorder (MDD) Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Major Depressive Disorder (MDD) Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Major Depressive Disorder (MDD) Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Major Depressive Disorder (MDD) Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Major Depressive Disorder (MDD) Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Major Depressive Disorder (MDD) Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Major Depressive Disorder (MDD) Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Major Depressive Disorder (MDD) Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Major Depressive Disorder (MDD) Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Major Depressive Disorder (MDD) Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Major Depressive Disorder (MDD) Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Major Depressive Disorder (MDD) Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Major Depressive Disorder (MDD) Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2022-2027) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Major Depressive Disorder (MDD) Product
Table 67. Pfizer Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. GlaxoSmithKline Company Details
Table 70. GlaxoSmithKline Business Overview
Table 71. GlaxoSmithKline Major Depressive Disorder (MDD) Product
Table 72. GlaxoSmithKline Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million)
Table 73. GlaxoSmithKline Recent Development
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Major Depressive Disorder (MDD) Product
Table 77. Merck Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million)
Table 78. Merck Recent Development
Table 79. AstraZeneca Company Details
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca Major Depressive Disorder (MDD) Product
Table 82. AstraZeneca Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million)
Table 83. AstraZeneca Recent Development
Table 84. Eli Lily Company Details
Table 85. Eli Lily Business Overview
Table 86. Eli Lily Major Depressive Disorder (MDD) Product
Table 87. Eli Lily Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million)
Table 88. Eli Lily Recent Development
Table 89. Johnson & Johnson Company Details
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Major Depressive Disorder (MDD) Product
Table 92. Johnson & Johnson Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million)
Table 93. Johnson & Johnson Recent Development
Table 94. Forest Laboratories Company Details
Table 95. Forest Laboratories Business Overview
Table 96. Forest Laboratories Major Depressive Disorder (MDD) Product
Table 97. Forest Laboratories Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million)
Table 98. Forest Laboratories Recent Development
Table 99. Sanofi-Aventis Company Details
Table 100. Sanofi-Aventis Business Overview
Table 101. Sanofi-Aventis Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million)
Table 102. Sanofi-Aventis Recent Development
Table 103. H. Lundbeck Company Details
Table 104. H. Lundbeck Business Overview
Table 105. H. Lundbeck Major Depressive Disorder (MDD) Product
Table 106. H. Lundbeck Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million)
Table 107. H. Lundbeck Recent Development
Table 108. Bristol-Myers Squibb Company Details
Table 109. Bristol-Myers Squibb Business Overview
Table 110. Bristol-Myers Squibb Major Depressive Disorder (MDD) Product
Table 111. Bristol-Myers Squibb Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million)
Table 112. Bristol-Myers Squibb Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Major Depressive Disorder (MDD) Market Share by Type: 2020 VS 2027
Figure 2. Antidepressant Drugs Features
Figure 3. SSRIs Features
Figure 4. SNRIs Features
Figure 5. Benzodiazepines Features
Figure 6. Others Features
Figure 7. Global Major Depressive Disorder (MDD) Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Major Depressive Disorder (MDD) Report Years Considered
Figure 12. Global Major Depressive Disorder (MDD) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Major Depressive Disorder (MDD) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Major Depressive Disorder (MDD) Market Share by Regions: 2020 VS 2027
Figure 15. Global Major Depressive Disorder (MDD) Market Share by Regions (2022-2027)
Figure 16. Global Major Depressive Disorder (MDD) Market Share by Players in 2020
Figure 17. Global Top Major Depressive Disorder (MDD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Major Depressive Disorder (MDD) as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Major Depressive Disorder (MDD) Revenue in 2020
Figure 19. Global Major Depressive Disorder (MDD) Revenue Market Share by Type (2016-2021)
Figure 20. Global Major Depressive Disorder (MDD) Revenue Market Share by Type (2022-2027)
Figure 21. North America Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Major Depressive Disorder (MDD) Market Share by Type (2016-2027)
Figure 23. North America Major Depressive Disorder (MDD) Market Share by Application (2016-2027)
Figure 24. North America Major Depressive Disorder (MDD) Market Share by Country (2016-2027)
Figure 25. United States Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Major Depressive Disorder (MDD) Market Share by Type (2016-2027)
Figure 29. Europe Major Depressive Disorder (MDD) Market Share by Application (2016-2027)
Figure 30. Europe Major Depressive Disorder (MDD) Market Share by Country (2016-2027)
Figure 31. Germany Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Major Depressive Disorder (MDD) Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Major Depressive Disorder (MDD) Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Major Depressive Disorder (MDD) Market Share by Region (2016-2027)
Figure 41. China Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Major Depressive Disorder (MDD) Market Share by Type (2016-2027)
Figure 49. Latin America Major Depressive Disorder (MDD) Market Share by Application (2016-2027)
Figure 50. Latin America Major Depressive Disorder (MDD) Market Share by Country (2016-2027)
Figure 51. Mexico Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Major Depressive Disorder (MDD) Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Major Depressive Disorder (MDD) Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Major Depressive Disorder (MDD) Market Share by Country (2016-2027)
Figure 57. Turkey Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Pfizer Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021)
Figure 63. AstraZeneca Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021)
Figure 64. Eli Lily Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021)
Figure 65. Johnson & Johnson Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021)
Figure 66. Forest Laboratories Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021)
Figure 67. Sanofi-Aventis Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021)
Figure 68. H. Lundbeck Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021)
Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の大うつ病性障害市場規模・現状・予測（2021年-2027年） Major depressive disorder, also known as major depression and clinical depression, is a mental disorder characterized by loss of interest and pleasure in enjoyable environment. People are affected in different ways by major depression. Some people have trouble sleeping, feel agitated and irritable, …- 世界の大うつ病性障害治療市場規模・現状・予測（2021年-2027年） Major depressive disorder, also known as major depression and clinical depression, is a mental disorder characterized by loss of interest and pleasure in enjoyable environment. People are affected in different ways by major depression. Some people have trouble sleeping, feel agitated and irritable, …
- 世界のうつ病性障害市場規模・現状・予測（2021年-2027年） Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including…
- 世界の慢性うつ病パーソナリティ障害治療市場規模・現状・予測（2021年-2027年） Chronic depressive personality disorder also known as Dysthymia is a chronic form of depression. It is mild form of depression which last up to two years or more. This disorder is less severe in comparison to other forms of depression. Symptoms of chronic depressive personality disorder are loss of …
- 世界の双極性障害治療市場規模・現状・予測（2021年-2027年） Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood. The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics. Market Analysis and Insights: Global Bipolar…